Interestingly, although HAS3 and HAS2 expression were upregulated in patients with GBM compared with patients with LGG, only HAS3 expression negatively correlated with the DFS time in both LGG and GBM patients (Supplementary Fig. 1B; Fig. 1D). The gene discussed is HAS2; the disease is glioblastoma.